Association Between Severity of COVID-19 and Social Determinants of Health with Adverse Pregnancy Outcomes in a Study of Mother-Infant Pairs in Los Angeles, California
- PMID: 40302893
- PMCID: PMC12037175
- DOI: 10.3390/women5020012
Association Between Severity of COVID-19 and Social Determinants of Health with Adverse Pregnancy Outcomes in a Study of Mother-Infant Pairs in Los Angeles, California
Abstract
Previous cross-sectional studies have investigated social determinants of health (SDOH) among pregnant women with COVID-19. However, there are scant data on the impact of these determinants on maternal outcomes from cohorts of pregnant women with COVID-19. We evaluated the association between social determinants of health and both COVID-19 severity and adverse pregnancy outcomes (APOs) in a cohort of pregnant women in Los Angeles (L.A.) County, California. The APOs considered were fetal loss, gestational hypertensive disorders, prolonged rupture of membranes, and maternal death. We recruited pregnant women with confirmed SARS-CoV-2 and collected data on maternal COVID-19 severity, trimester at diagnosis, comorbidities, mode of delivery, COVID-19 vaccination, APOs, maternal age, medical insurance type, race/ethnicity, and neighborhood income. Participants who were obese were more likely to experience severe COVID-19 (OR: 3.61, 95% CI: 1.44-9.46), while even one vaccine dose before COVID-19 infection was associated with reduced odds of severe disease (OR:0.14, 95% CI: 0.02-0.52). Pregnant participants living in low-income areas were more likely to experience APOs (p = 0.01) and severe COVID-19 (p = 0.009). This suggests that economic inequities could negatively impact maternal outcomes among pregnant women with COVID-19. We also found that SDOH moderated severity effects on APOs in Black women vs. non-Black women. These findings underscore the importance of considering social determinants of health to improve maternal health.
Keywords: COMP cohort; COVID-19 severity; adverse pregnancy outcomes; pregnancy; social determinants of health.
Conflict of interest statement
Conflicts of Interest: The authors declare no conflicts of interest.
Figures





Similar articles
-
COVID-19 vaccination during pregnancy: coverage and safety.Am J Obstet Gynecol. 2022 Feb;226(2):236.e1-236.e14. doi: 10.1016/j.ajog.2021.08.007. Epub 2021 Aug 10. Am J Obstet Gynecol. 2022. PMID: 34389291 Free PMC article.
-
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.Am J Obstet Gynecol. 2021 Nov;225(5):522.e1-522.e11. doi: 10.1016/j.ajog.2021.05.016. Epub 2021 May 20. Am J Obstet Gynecol. 2021. PMID: 34023315 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Gestational diabetes mellitus and COVID-19: results from the COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS).Am J Obstet Gynecol. 2022 Oct;227(4):631.e1-631.e19. doi: 10.1016/j.ajog.2022.05.027. Epub 2022 May 14. Am J Obstet Gynecol. 2022. PMID: 35580632 Free PMC article.
-
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.BMJ. 2020 Sep 1;370:m3320. doi: 10.1136/bmj.m3320. BMJ. 2020. Update in: BMJ. 2022 May 30;377:o1205. doi: 10.1136/bmj.o1205. PMID: 32873575 Free PMC article. Updated.
References
-
- Villar J; Soto Conti CP; Gunier RB; Ariff S; Craik R; Cavoretto PI; Rauch S; Gandino S; Nieto R; Winsey A; et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: A multinational, observational study. Lancet 2023, 401, 447–457. - PMC - PubMed
-
- Cambou MC; Liu CM; Mok T; Fajardo-Martinez V; Paiola SG; Ibarrondo FJ; Kerin T; Fuller T; Tobin NH; Garcia G; et al. Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. J. Infect. Dis 2023, 227, 236–245. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous